SCHEMBL396689

SCHEMBL396689

O=C(CC(F)(F)F)c1ccc(C(=O)CC(F)(F)F)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.48
GSK3B P49841 4/20 0.48
PLOD2 O00469 2/20 0.47
GAA P10253 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MMP1 P03956 1/20 0.41
CES1 P23141 2/20 0.41
CES2 O00748 1/20 0.41
PLOD3 O60568 1/20 0.41
PLOD1 Q02809 1/20 0.41
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NR4A1 P22736 1/20 0.39
NR4A2 P43354 1/20 0.39
NR4A3 Q92570 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2074862 0.91 PLOD2 (0.60) PTPN1GSK3BPLOD2NPC1RAB9A
SCHEMBL20202561 0.89 GSK3B (0.55) GSK3BGAANPC1RAB9ACES1
SCHEMBL22163776 0.89 GSK3B (0.57) PTPN1GSK3BNPC1RAB9ACES1
SCHEMBL28418536 0.89 TPMT (0.46) PTPN1GSK3BPLOD2GAANPC1
SCHEMBL10812330 0.89 GSK3B (0.57) GSK3BNPC1RAB9ACES1CES2
SCHEMBL6630244 0.89 PTPN1 (0.66) PTPN1GSK3BMMP1CES1CES2
SCHEMBL70367 0.88 CES1 (0.56) PTPN1GSK3BPLOD2GAANPC1
Hydrogen Sulfide SCHEMBL28313848 0.86 TDP1 (0.54) PTPN1GSK3BPLOD2GAANPC1
SCHEMBL28612795 0.85 PTPN1 (0.39) PTPN1GSK3BPLOD2GAANPC1
SCHEMBL28729892 0.85 RAB9A (0.58) PTPN1GSK3BNPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101290-B2 Organic compound having electron-transporting and/or hole-blocking performance and its use and OLEDs comprising the compound TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY OF CHINESE ACADEMY OF SCIENCES (CN) 2012-01-24 US disclosed
US-20090102356-A1 NOVEL ORGANIC COMPOUND HAVING ELECTRON-TRANSPORTING AND/OR HOLE-BLOCKING PERFORMANCE AND ITS USE AND OLEDs COMPRISING THE COMPOUND TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY OF CHINESE ACADEMY OF SCIENCES (CN) 2009-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090102356-A1 NOVEL ORGANIC COMPOUND HAVING ELECTRON-TRANSPORTING AND/OR HOLE-BLOCKING PERFORMANCE AND ITS USE AND OLEDs COMPRISING THE COMPOUND SLCO4C1, SLCO1B1, SLCO2B1 PTPN1 4491/4885GSK3B 2732/4885PLOD2 1240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.